Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check6 days agoChange DetectedAdded related topics links for Cystic fibrosis and MedlinePlus Genetics. These are supplementary navigation aids and do not alter core study content or decisions about participation.SummaryDifference0.2%

- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding lapse notice and related topics such as Cystic fibrosis and Revision: v3.4.1.SummaryDifference0.6%

- Check20 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated operating status information; the page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdditions include Show glossary, Cystic fibrosis, related topics (MedlinePlus Genetics), and metadata updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); deletions remove Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedRevision: v3.3.4 has been added, replacing v3.3.3. This appears to be an internal version update.SummaryDifference0.1%

- Check56 days agoChange DetectedCystic fibrosis and MedlinePlus Genetics topics were removed from the page, affecting visibility of CF-related study details and resources.SummaryDifference0.2%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.